NGM Biopharmaceuticals, Inc. is a clinical stage biotech company dedicated to discovering and developing the next generation of medicines for the treatment of serious diseases. Our experienced scientific team has joined forces with an impressive group of industry professionals, Nobel Laureates and other distinguished researchers to form a company where innovation and cutting-edge science has provided the foundation for a robust drug discovery engine. To date, NGM Bio has generated a pipeline of seven drug candidates in various stages of development targeting liver, metabolic and ophthalmic diseases and cancer. The most advanced drug candidate, NGM282, is entering Phase 2b clinical studies in non-alcoholic steatohepatitis (NASH). NGM’s strategic collaboration with Merck, which was extended to March 2022, will continue to provide us with the resources and flexibility to pursue our ambitious R&D goals and further extend our pipeline of novel drug candidates.
NGM currently has an opening for a highly motivated individual to join our CMC team. The team is responsible for progressing NGM’s cutting edge science derived protein therapeutics from the research lab to the clinic. The position in Downstream Process Development will carry out downstream technical activities to support both early stage and late stage clinical development projects. The position requires knowledge and hands-on experience of lab-based purification development. The successful candidate shall be independent, team oriented, and efficient in multitasking.
NGM offers a creative, collaborative, highly challenging scientific environment.
Contract term length 3 months, with possibility to extend.
Interested applicants should apply through the NGM Biopharmaceuticals website: http://www.ngmbio.com/careers/#SilkroadFrame